a Cohort Study (Gut Microbiota and HCC)

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

May 20, 2026

Study Completion Date

November 20, 2026

Conditions
Liver Cancer
All Listed Sponsors
collaborator

Nanjing Xiershou Biotechnology Co., Ltd

UNKNOWN

lead

Xu Yong, MD

OTHER

NCT06557213 - a Cohort Study (Gut Microbiota and HCC) | Biotech Hunter | Biotech Hunter